Invesco S&P MidCap 400® Pure Growth ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Invesco S&P MidCap 400® Pure Growth ETF RFG
Morningstar’s Analysis RFG
Will RFG outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Halozyme Therapeutics Inc | 2.67 | 9M | Healthcare |
Twilio Inc Class A | 2.37 | 8M | Technology |
DigitalOcean Holdings Inc | 2.23 | 7M | Technology |
Vicor Corp | 2.11 | 7M | Technology |
TechnipFMC PLC | 2.07 | 7M | Energy |
Sterling Infrastructure Inc | 1.94 | 6M | Industrials |
InterDigital Inc | 1.91 | 6M | Technology |
Arrowhead Pharmaceuticals Inc | 1.90 | 6M | Healthcare |
Medpace Holdings Inc | 1.84 | 6M | Healthcare |
Corcept Therapeutics Inc | 1.74 | 6M | Healthcare |